AI-powered search
Try Polaris, our new AI-powered search!

Why do we need to better assess SCC prognosis?

Featuring Darrell Rigel, MD, MS | Senior Clinical Advisor |

Clinical Professor of Dermatology 
New York University
Grossman School of Medicine
New York, NY 

| Published August 01, 2023

Summary 

In the video, Dr. Darrell Rigel discusses the significance of better assessing the prognosis of squamous cell carcinoma (SCC), including cutaneous SCC. He emphasizes that SCC is a serious disease and can lead to fatalities. Therefore, it is crucial to have an accurate prognosis assessment to determine which patients require further therapy. Understanding the prognosis allows healthcare professionals to provide appropriate and timely treatment for those affected by SCC. 

Key Points 
  • Squamous cell carcinoma (SCC) is a serious disease, including cutaneous squamous cell carcinoma, and it can lead to fatalities. 
  • Accurate assessment of SCC prognosis is essential to determine the appropriate course of action for patients, including the need for further therapy.  
  • Prognosis assessment helps in identifying high-risk patients who may require more intensive treatments and monitoring.  
  • Early identification of patients with poor prognosis can potentially improve outcomes and increase survival rates. 
  • Tailoring treatment plans based on prognosis can help avoid over-treatment in low-risk cases and provide more aggressive approaches for high-risk cases. 
  • Monitoring prognosis allows healthcare professionals to make informed decisions and adjustments in treatment strategies as the disease progresses. 
  • Improved prognosis assessment contributes to a more personalized and effective approach to managing SCC patients. 
  • Research and advancements in prognosis assessment may lead to better understanding of SCC's behavior and potential new treatment options. 
  • Overall, accurate prognosis assessment is crucial for enhancing the management and outcomes of individuals with SCC.

More from this series

How do you discuss 40-GEP test results with patients?

Skin Cancer

How do you discuss 40-GEP test results with patients?

Featuring Darrell Rigel, MD, MS

What are the trends in US incidence of SCC?

Skin Cancer

What are the trends in US incidence of SCC?

Featuring Darrell Rigel, MD, MS

What SCCs are appropriate for the 40-GEP test?

Skin Cancer

What SCCs are appropriate for the 40-GEP test?

Featuring Darrell Rigel, MD, MS

How does the 40-GEP test work?

Skin Cancer

How does the 40-GEP test work?

Featuring Darrell Rigel, MD, MS

Related Media

Powered by Polaris TM
What are the trends in US incidence of SCC?

Darrell S. Rigel

Why doesn't SCC get the respect it should?

Darrell S. Rigel

Accurately Assessing Prognosis for High-Risk Squamous Cell Carcinoma

Danny Zakria, MD, MBA, Ryan Rivera-Oyola, MD, Darrell Rigel, MD, MS